These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26064049)

  • 21. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
    Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.
    Williams JW; Barrett J; Oxman T; Frank E; Katon W; Sullivan M; Cornell J; Sengupta A
    JAMA; 2000 Sep; 284(12):1519-26. PubMed ID: 11000645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety.
    Yargic LI; Corapcioglu A; Kocabasoglu N; Erdogan A; Koroglu G; Yilmaz D
    Int J Psychiatry Clin Pract; 2004; 8(4):205-11. PubMed ID: 24930548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L; Septien L; Azoulay P
    CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial.
    Wang Z; Xu X; Tan Q; Li K; Ma C; Xie S; Gao C; Wang G; Li H
    Shanghai Arch Psychiatry; 2015 Aug; 27(4):228-36. PubMed ID: 26549959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Web-Based Cognitive Behavior Therapy for Depression in People With Diabetes Mellitus: A Randomized Controlled Trial.
    Newby J; Robins L; Wilhelm K; Smith J; Fletcher T; Gillis I; Ma T; Finch A; Campbell L; Andrews G
    J Med Internet Res; 2017 May; 19(5):e157. PubMed ID: 28506956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.
    Boulenger JP; Hermes A; Huusom AK; Weiller E
    Curr Med Res Opin; 2010 Mar; 26(3):605-14. PubMed ID: 20067433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine
    Callegari C; Ielmini M; Caselli I; Lucca G; Isella C; Diurni M; Pettenon F; Poloni N
    Psychopharmacol Bull; 2019 Feb; 49(1):28-43. PubMed ID: 30858637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
    Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
    CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
    Fava M; Amsterdam JD; Deltito JA; Salzman C; Schwaller M; Dunner DL
    Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression.
    Tignol J
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):18S-22S. PubMed ID: 8106650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE.
    Medvedev VE
    Neuropsychiatr Dis Treat; 2017; 13():1141-1151. PubMed ID: 28461750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in quality of life in depressed patients following verum acupuncture or electroacupuncture plus paroxetine: A randomized controlled study of 157 cases.
    Ma S; Qu S; Huang Y; Chen J; Lin R; Wang C; Li G; Zhao C; Guo S; Zhang Z
    Neural Regen Res; 2012 Sep; 7(27):2123-9. PubMed ID: 25558225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Depression in Patients with Type II Diabetes Mellitus and its Impact on Quality of Life.
    Das R; Singh O; Thakurta RG; Khandakar MR; Ali SN; Mallick AK; Roy P; Bhattacharrya AK
    Indian J Psychol Med; 2013 Jul; 35(3):284-9. PubMed ID: 24249932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients.
    Chaudhary R; Kumar P; Chopra A; Chabbra S; Singh P
    Indian J Psychol Med; 2017; 39(3):342-346. PubMed ID: 28615771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.